Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth

This study is looking at how a group therapy called Facing Your Fears (FYF) affects brain activity and anxiety in autistic youth aged 8 to 14. FYF is a type of cognitive behavioral therapy (CBT) that helps children and teenagers with anxiety. Researchers want to see if brain activity changes are linked to improvements in anxiety after treatment. You might receive the FYF therapy right away, or you might be in a group that continues with your usual care for a while before getting the FYF therapy. The study will measure anxiety levels using questionnaires completed by you and your parents, both at the beginning and after the intervention.

Study design
This is an interventional study planning to enroll 60 participants. It compares those receiving immediate FYF therapy to those on a waitlist who receive usual care.
What's involved
You will complete assessments at the beginning of the study and within two weeks after the intervention ends, which could be up to 14 weeks after the first therapy session.
Compensation
Not stated in the trial record.
Follow-up
Participants will be assessed within two weeks of intervention completion, up to 14 weeks after the first intervention session.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06904508

Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities

Recruiting
NAAges 8–14InterventionalBasic science
Montclair State University
~60 participants
Updated 2025-06-25 on ClinicalTrials.gov
What's tested:Facing Your Fears (FYF) Intervention: A CBT Focused Group Treatment for Autistic Youth with Anxiety

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The Screen for Child Anxiety and Related Disorders (SCARED-P/C)
Measured over Baseline and within 2 weeks of intervention completion (up to 14 weeks post first intervention session)
+4 more outcomes measured
Autism Spectrum Disorder
Anxiety

NCT06904508

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Drexel University

    Philadelphia, Pennsylvaniastudy coordinator listed

    Recruiting

  • Montclair State University

    Montclair, New Jerseystudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Erin Kang, PhD · PRINCIPAL_INVESTIGATOR · Montclair State University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Between the ages of 8 and 14
Have significant deficits in reciprocal social behavior as defined by a score of 11 or above on the parent-report SCQ questionnaire
Are verbally fluent in English, enabling them to participate in the appropriate modules (3 or 4) of the researcher-administered ADOS-2
Have an estimated verbal IQ of 70 or above as determined by the researcher-administered KBIT-2
Have clinically significant anxiety symptoms as defined by significant elevations on either the parent-report SCARED questionnaire or the parent-report PRAS-ASD questionnaire
Have a legal guardian who can provide consent for their child's participation as well as their own participation in the intervention alongside their child. If the legal guardian is unable to participate in the intervention themselves but would like for their child to receive the intervention with another caregiver who lives with the child, the legal guardian will still be the one to sign the consent form, but will provide permission for another caregiver (logged on the consent form) to participate in the intervention alongside the child
If it is determined by the research team via parent report or direct observation that the child has a severe medical or psychiatric impairment (e.g., psychosis, severe aggressive behavior, or other severe clinical symptoms) that require more intensive treatment such as day treatment or hospitalization
  • The Screen for Child Anxiety and Related Disorders (SCARED-P/C)Baseline and within 2 weeks of intervention completion (up to 14 weeks post first intervention session)

    The Screen for Child Anxiety and Related Disorders - Parent/Child versions (SCARED-P/C) is comprised of five anxiety subscales, including panic, generalized anxiety, separation anxiety, and school avoidance symptoms, and a total anxiety subscale. The SCARED-P and SCARED-C each include 41 items designed to evaluate a child's recent anxiety symptoms. Participants rate their responses on a 3-point Likert scale: 0 (Not True or Hardly Ever True), 1 (Somewhat or Sometimes True), and 2 (Very True or Often True). A total score of 25 or higher is considered indicative of clinically significant anxiety. The SCARED has shown good psychometric properties across autistic and non-autistic samples. It has shown evidence for treatment sensitivity in previous FYF trials, and will be used as a primary outcome measure in this study as well.

  • Anxiety Scale for Children-Autism Spectrum Disorder Scale (ASC-ASD)Baseline and within 2 weeks of intervention completion (up to 14 weeks post first intervention session)

    The Anxiety Scale for Children-Autism Spectrum Disorder Scale (ASC-ASD) is a self- and parent-report measure developed to assess separation anxiety, uncertainty, performance anxiety, and anxious arousal dimensionally in the autistic population. It consists of 25-items (scored 0-3) with higher scores indicating higher anxiety levels..

  • Parent Rated Anxiety Scale for Autism Spectrum Disorder (PRAS-ASD)Baseline and within 2 weeks of intervention completion (up to 14 weeks post first intervention session)

    It consists of 25-items (scored 0-3) with higher scores indicating higher anxiety levels. This measure was developed to assess DSM-5 and anxiety symptoms distinct to ASD, specifically this measure takes the unique approach of examining behaviorally oriented anxiety symptoms. This measure has demonstrated reliability and validity in the autism population.

  • Error Related Negativity (ERN) Event-Related Potential (ERP)Baseline and within 2 weeks of intervention completion (up to 14 weeks post first intervention session)

    EEG systems will be used to record Error Related Negativity using the Flanker paradigm. The Flanker paradigm involves congruent (50%) and incongruent (50%) trials with arrows facing the same direction as (congruent) or the opposite direction of (incongruent) the target. The order of congruent and incongruent trials will be random. All stimuli will be presented for 200 ms followed by an inter-trial interval that varies randomly from 2,300 to 2,800 ms. The participant will be given detailed task instructions, and receive feedback based on their performance at the end of each block. Error and correct trials will be separately averaged, with the error response as the mean activity between -25 and 75ms after the error response at scalp site where error-related brain activity is maximal. In addition, the correct response negativity (CRN) will be evaluated for the same time window and site on correct trials. The ERN (i.e., the error response minus CRN) will then be calculated for analysis

  • Electroencephalogram (EEG) Hemispheric AsymmetryBaseline and within 2 weeks of intervention completion (up to 14 weeks post first intervention session)

    Resting EEG data will be collected for 6 minutes alternating between 1-min blocks of eyes open or closed (with the order counterbalanced across subjects). Baseline frontal alpha-band power during eyes-open rest will be calculated across the epoch using wavelet analysis for central frequencies (7.5-12.5 Hz) using 20 logarithmic steps at 7 cycles. To normalize the data, natural log-transformed scores will be calculated. Asymmetry scores were created as Ln(Left) - Ln(Right) for mean alpha power across F3(L)/4(R) and F7(L)/8(R) pairs.